Jan Pinkas

Insider Reports History

Location
Waltham, MA
Signature
/s/ Barbara Bispham, as attorney-in-fact for Jan Pinkas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jan Pinkas:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRESCENT BIOPHARMA, INC. Chief Scientific Officer Ordinary Shares 22,507 $339,405 $15.08 15 Dec 2025 Direct
CRESCENT BIOPHARMA, INC. Chief Scientific Officer Stock Option (Right to Buy) 70,025 15 Dec 2025 Direct

Insider Reports Filed by Jan Pinkas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLYC CRESCENT BIOPHARMA, INC. 15 Dec 2025 3 $0 4 Chief Scientific Officer 17 Dec 2025, 16:49
GLYC CRESCENT BIOPHARMA, INC. 16 Jul 2025 1 $0 4 Chief Scientific Officer 16 Jul 2025, 19:11
GLYC CRESCENT BIOPHARMA, INC. 07 Jul 2025 0 $0 3 Chief Scientific Officer 15 Jul 2025, 16:16